SEC Form 4 · accession 0001645627-18-000080
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Dec 14, 2018
Accepted (ET)
Dec 20, 2018 · 11:50 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 14, 2018 | P | 2,000 | $0.0227 | A | 26,360,898 | D | |
| Common Stock | Dec 17, 2018 | P | 1,000 | $0.0212 | A | 26,361,898 | D | |
| Common Stock | Dec 17, 2018 | P | 1,000 | $0.021 | A | 26,362,898 | D | |
| Common Stock | Dec 17, 2018 | P | 1,000 | $0.0222 | A | 26,363,898 | D | |
| Common Stock | Dec 19, 2018 | P | 1,000 | $0.0219 | A | 26,364,898 | D | |
| Common Stock | Dec 19, 2018 | P | 1,000 | $0.0219 | A | 26,365,898 | D | |
| Common Stock | Dec 20, 2018 | P | 1,000 | $0.0208 | A | 26,366,898 | D | |
| Common Stock | Dec 20, 2018 | P | 1,000 | $0.0206 | A | 26,367,898 | D |
Table II — derivative securities
No Table II lines on this filing.